The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia

Alan L. Hillman, J. Sanford Schwartz, Mary Kaye Willian, Ellen Peskin, Claus G. Roehrborn, Joseph E. Oesterling, Michael F. Mason, Clem J. Maurath, Patricia A. Deverka, Robert J. Padley

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences